LifeSiteNews.com

Friday April 25, 2003



     

DEPO-PROVERA LEADS TO 100 TIMES GREATER HERPES SUSCEPTABILITY

HAMILTON, ON, April 25, 2003 (LifeSiteNews.com) - Researchers at McMaster University have found that the abortifacient injectable birth-control drug Depo-Provera caused mice to be 100 times more susceptible to infection with herpes simplex virus type 2 (HSV-2).

The study, published in the current issue of the Journal of Virology (2003;77:4558-4565), also found that the mice injected with the drug had a significantly weaker immune response when exposed to the virus.

While spokesman for Pfizer, the pharmaceutical which manufactures Depo-Provera, were quick to condemn the study, the researchers noted that the study merely confirmed former research noting the drug increased risk of STDs.

See the Reuters coverage:
http://asia.reuters.com/newsArticle.jhtml?type=healthNews&st...

Back to Top Back to Top


SHARE THIS STORY: E-mail  Print  Newsvine  Digg  Reddit  Del.icio.us  Facebook



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any Internet re-publishing of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. Republishing of articles on LifeSiteNews that have come from other news sources as noted is subject to the conditions of those sources.